Cholinergic Nicotinic Agonist [EPC]

Cholinergic Nicotinic Agonist [EPC] was reported 61214 times

Drugs of the Cholinergic Nicotinic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NICOTINE DEPENDENCE 6185 0.7944
1 TOBACCO POISONING 70 0.6481
2 VAGINAL FLATULENCE 188 0.6205
3 APPLICATION SITE BRUISING 35 0.5738
4 RHESUS INCOMPATIBILITY 68 0.5620
5 TRUNCUS ARTERIOSUS PERSISTENT 77 0.3869
6 APPLICATION SITE HYPERAESTHESIA 28 0.2828
7 APPLICATION SITE DERMATITIS 251 0.2684
8 APPLICATION SITE URTICARIA 493 0.2194
9 APPLICATION SITE PERSPIRATION 33 0.1908
10 MYOCARDIAL STUNNING 25 0.1866
11 APPLICATION SITE PAPULES 196 0.1847
12 INTENTIONAL DRUG MISUSE 3782 0.1807
13 RIB DEFORMITY 44 0.1732
14 TOBACCO WITHDRAWAL SYMPTOMS 29 0.1657
15 APPLICATION SITE PRURITUS 3517 0.1549
16 APPLICATION SITE SWELLING 747 0.1497
17 TOBACCO ABUSE 75 0.1404
18 APPLICATION SITE REACTION 984 0.1398
19 APPLICATION SITE WARMTH 176 0.1379
20 APPLICATION SITE ERYTHEMA 3567 0.1360
21 LUNG DIFFUSION DISORDER 19 0.1210
22 FEMALE GENITAL TRACT FISTULA 192 0.1123
23 APPLICATION SITE RASH 1378 0.1001
24 APPLICATION SITE IRRITATION 1229 0.0987
25 ORAL MUCOSAL DISCOLOURATION 64 0.0964
26 APPLICATION SITE PARAESTHESIA 125 0.0959
27 TOOTH EROSION 107 0.0873
28 REVERSIBLE AIRWAYS OBSTRUCTION 43 0.0846
29 CARDIAC SEPTAL DEFECT 57 0.0793
30 HICCUPS 649 0.0790
31 TOBACCO USER 115 0.0776
32 TREMOR NEONATAL 33 0.0740
33 APPLICATION SITE BLEEDING 18 0.0729
34 RADICULOPATHY 192 0.0728
35 CONGENITAL CARDIOVASCULAR ANOMALY 60 0.0715
36 MULTIPLE DRUG OVERDOSE ACCIDENTAL 32 0.0700
37 CHRONIC SINUSITIS 262 0.0697
38 MACULAR DEGENERATION 830 0.0694
39 PROCTITIS 193 0.0688
40 PRODUCT ADHESION ISSUE 2362 0.0660
41 SALIVA DISCOLOURATION 21 0.0629
42 APPLICATION SITE BRUISE 61 0.0627
43 DRUG ABUSER 365 0.0593
44 PRODUCT SELECTION ERROR 65 0.0593
45 APPLICATION SITE VESICLES 379 0.0584
46 APPLICATION SITE PAIN 1279 0.0580
47 ORAL DISCOMFORT 787 0.0566
48 APPLICATION SITE SCAR 68 0.0543
49 IDIOPATHIC INTERSTITIAL PNEUMONIA 19 0.0537
50 TOOTH DISCOLOURATION 155 0.0526
51 MEDIASTINAL MASS 20 0.0522
52 JAUNDICE NEONATAL 98 0.0517
53 POSTMORTEM BLOOD DRUG LEVEL INCREASED 19 0.0509
54 APPLICATION SITE HYPERSENSITIVITY 61 0.0502
55 DRUG ADMINISTRATION ERROR 1529 0.0498
56 ADENOIDECTOMY 19 0.0490
57 GINGIVAL BLISTER 21 0.0479
58 APPLICATION SITE BURN 233 0.0473
59 APPLICATION SITE INFLAMMATION 63 0.0455
60 PULMONARY EOSINOPHILIA 20 0.0437
61 NECROSIS ISCHAEMIC 20 0.0434
62 ABNORMAL DREAMS 1192 0.0431
63 GINGIVAL DISCOMFORT 28 0.0424
64 BREECH PRESENTATION 49 0.0389
65 AGITATION NEONATAL 37 0.0386
66 FOETAL DISORDER 32 0.0383
67 SPUTUM PURULENT 25 0.0380
68 GINGIVAL DISCOLOURATION 20 0.0372
69 SUBSTANCE DEPENDENCE 25 0.0371
70 EXPOSURE DURING BREAST FEEDING 120 0.0362
71 GINGIVAL ULCERATION 27 0.0359
72 APPLICATION SITE DISCOLOURATION 145 0.0357
73 APPLICATION SITE DISCOMFORT 60 0.0334
74 EXPOSURE VIA BREAST MILK 130 0.0326
75 APPLICATION SITE EROSION 42 0.0326
76 EXPIRED DRUG ADMINISTERED 156 0.0315
77 APPLICATION SITE ULCER 22 0.0311
78 STOMACH DISCOMFORT 158 0.0306
79 DIAPHRAGMATIC DISORDER 23 0.0301
80 OROPHARYNGEAL BLISTERING 49 0.0300
81 TREATMENT NONCOMPLIANCE 1599 0.0292
82 PARAESTHESIA ORAL 404 0.0280
83 BRONCHIAL WALL THICKENING 20 0.0278
84 APPLICATION SITE SCAB 60 0.0278
85 FEELING OF RELAXATION 19 0.0277
86 PRODUCT COMPLAINT 688 0.0271
87 DRUG WITHDRAWAL SYNDROME NEONATAL 402 0.0271
88 PHARYNGEAL HYPOAESTHESIA 25 0.0269
89 INCORRECT DRUG ADMINISTRATION DURATION 756 0.0269
90 OBSESSIVE THOUGHTS 48 0.0266
91 GINGIVAL PAIN 203 0.0255
92 FOETAL DISTRESS SYNDROME 54 0.0254
93 LIP DISCOLOURATION 32 0.0253
94 APPLICATION SITE DISCHARGE 29 0.0251
95 DRUG DETOXIFICATION 22 0.0246
96 TONGUE DISCOLOURATION 107 0.0244
97 APPLICATION SITE DRYNESS 81 0.0238
98 APPLICATION SITE EXFOLIATION 98 0.0238
99 DENTAL CARIES 260 0.0235
100 NASAL OBSTRUCTION 44 0.0234
101 LOW BIRTH WEIGHT BABY 186 0.0234
102 OEDEMA MOUTH 74 0.0226
103 THERMAL BURN 157 0.0221
104 PNEUMONIA STREPTOCOCCAL 24 0.0219
105 EXPIRED PRODUCT ADMINISTERED 726 0.0218
106 NIGHTMARE 754 0.0218
107 ALCOHOL ABUSE 58 0.0217
108 SUBSTANCE ABUSE 174 0.0214
109 TONGUE DISCOMFORT 90 0.0212
110 PRODUCT AFTER TASTE 20 0.0210
111 GLOSSITIS 74 0.0208
112 ALCOHOL WITHDRAWAL SYNDROME 18 0.0207
113 TONGUE BLISTERING 46 0.0206
114 PULMONARY GRANULOMA 23 0.0201
115 PHARYNGOLARYNGEAL PAIN 106 0.0199
116 ORAL MUCOSAL EXFOLIATION 30 0.0198
117 SECONDARY IMMUNODEFICIENCY 24 0.0198
118 VAGINAL DISCHARGE 200 0.0197
119 DERMATITIS CONTACT 222 0.0194
120 NONSPECIFIC REACTION 105 0.0191
121 SENSITIVITY OF TEETH 33 0.0191
122 EUPHORIC MOOD 195 0.0190
123 ACCIDENTAL EXPOSURE 77 0.0185
124 PRODUCT QUALITY ISSUE 2503 0.0184
125 ORAL MUCOSAL ERUPTION 28 0.0182
126 MICROCEPHALY 23 0.0179
127 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 22 0.0175
128 INTENTIONAL MISUSE 33 0.0173
129 THROAT IRRITATION 775 0.0173
130 DRUG EFFECT INCREASED 54 0.0171
131 GINGIVAL DISORDER 65 0.0169
132 ORAL CANDIDIASIS 221 0.0168
133 HEART DISEASE CONGENITAL 59 0.0167
134 BRONCHIAL HYPERREACTIVITY 20 0.0166
135 MULTIPLE DRUG OVERDOSE 82 0.0165
136 VENTRICULAR SEPTAL DEFECT 93 0.0162
137 PREMATURE DELIVERY 258 0.0162
138 ALCOHOL INTERACTION 31 0.0159
139 MOUTH INJURY 24 0.0158
140 BRONCHIAL SECRETION RETENTION 20 0.0157
141 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 31 0.0157
142 TENSION 95 0.0156
143 FEELING JITTERY 297 0.0156
144 APHTHOUS STOMATITIS 35 0.0152
145 ACCIDENTAL DEATH 28 0.0151
146 CHEST X-RAY ABNORMAL 46 0.0150
147 PRODUCT PACKAGE ASSOCIATED INJURY 33 0.0148
148 COUNTERFEIT PRODUCT ADMINISTERED 19 0.0146
149 OPHTHALMOPLEGIA 23 0.0146
150 SCHIZOAFFECTIVE DISORDER 26 0.0146
151 ORAL PAIN 324 0.0145
152 PHARMACEUTICAL PRODUCT COMPLAINT 365 0.0140
153 PREMATURE SEPARATION OF PLACENTA 21 0.0136
154 ORAL MUCOSAL ERYTHEMA 21 0.0136
155 NASAL OEDEMA 24 0.0133
156 LIP DISORDER 25 0.0132
157 INCORRECT PRODUCT ADMINISTRATION DURATION 284 0.0131
158 GINGIVAL RECESSION 25 0.0130
159 TOOTHACHE 234 0.0129
160 GINGIVAL SWELLING 57 0.0129
161 NEPHROGENIC ANAEMIA 59 0.0127
162 JAW FRACTURE 27 0.0125
163 OROPHARYNGEAL DISCOMFORT 113 0.0125
164 CLEFT PALATE 24 0.0124
165 SALIVARY HYPERSECRETION 123 0.0123
166 EMPHYSEMA 123 0.0122
167 TONGUE ULCERATION 41 0.0121
168 PREMATURE BABY 365 0.0121
169 APPLICATION SITE HAEMORRHAGE 33 0.0121
170 THROAT CLEARING 45 0.0120
171 PERIODONTITIS 26 0.0120
172 HYPERPARATHYROIDISM SECONDARY 30 0.0120
173 TONSILLECTOMY 20 0.0120
174 TOOTH FRACTURE 130 0.0118
175 MYCOBACTERIAL INFECTION 20 0.0116
176 NERVOUSNESS 599 0.0115
177 GLOSSODYNIA 255 0.0114
178 TOOTH INJURY 49 0.0113
179 OESOPHAGEAL PAIN 44 0.0111
180 BREATH ODOUR 27 0.0111
181 OLIGOHYDRAMNIOS 35 0.0105
182 DRUG SCREEN POSITIVE 82 0.0104
183 RETCHING 221 0.0104
184 CHOKING SENSATION 57 0.0103
185 PRODUCT TASTE ABNORMAL 136 0.0100
186 GAMBLING DISORDER 27 0.0100
187 CLOSTRIDIUM TEST POSITIVE 22 0.0100
188 ANTIPSYCHOTIC DRUG LEVEL INCREASED 28 0.0099
189 METHAEMOGLOBINAEMIA 23 0.0099
190 REBOUND ACID HYPERSECRETION 30 0.0099
191 FOAMING AT MOUTH 20 0.0099
192 FOETAL EXPOSURE DURING PREGNANCY 791 0.0097
193 SENSATION OF FOREIGN BODY 82 0.0097
194 COMPULSIVE SHOPPING 20 0.0097
195 DYSPEPSIA 952 0.0097
196 PHARYNGEAL OEDEMA 147 0.0095
197 FULL BLOOD COUNT ABNORMAL 97 0.0092
198 TONGUE DISORDER 66 0.0091
199 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1813 0.0089
200 PSYCHOMOTOR HYPERACTIVITY 148 0.0089
201 DYSGEUSIA 662 0.0089
202 DEPENDENCE 487 0.0089
203 HOMICIDAL IDEATION 36 0.0089
204 FREQUENT BOWEL MOVEMENTS 238 0.0088
205 GINGIVITIS 47 0.0087
206 PHARYNGEAL DISORDER 25 0.0087
207 MATERNAL DRUGS AFFECTING FOETUS 66 0.0086
208 ALCOHOL POISONING 23 0.0086
209 AORTIC ARTERIOSCLEROSIS 22 0.0085
210 PAIN IN JAW 241 0.0085
211 PROCEDURAL PAIN 235 0.0085
212 REGURGITATION 29 0.0084
213 ORAL PRURITUS 19 0.0083
214 BLOOD IMMUNOGLOBULIN E INCREASED 20 0.0083
215 ORAL DISORDER 60 0.0082
216 NASAL DISCOMFORT 64 0.0081
217 DRUG EFFECT LESS THAN EXPECTED 119 0.0080
218 IRRITABILITY 481 0.0080
219 VASODILATATION 20 0.0079
220 VITAMIN B12 DEFICIENCY 32 0.0079
221 PANIC REACTION 57 0.0079
222 OVERDOSE 1697 0.0079
223 DRUG TOXICITY 107 0.0078
224 PRURITUS GENERALISED 168 0.0078
225 LIP PAIN 22 0.0077
226 METABOLIC ENCEPHALOPATHY 23 0.0077
227 SMALL FOR DATES BABY 38 0.0076
228 ECONOMIC PROBLEM 115 0.0076
229 PRE-ECLAMPSIA 36 0.0076
230 PRODUCT ADMINISTRATION INTERRUPTED 59 0.0075
231 LEFT VENTRICULAR HYPERTROPHY 32 0.0075
232 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 390 0.0075
233 HEART RATE INCREASED 739 0.0075
234 ABORTION INDUCED 70 0.0074
235 PREMATURE LABOUR 42 0.0074
236 MOUTH ULCERATION 156 0.0074
237 CAESAREAN SECTION 86 0.0074
238 SKIN ODOUR ABNORMAL 29 0.0074
239 TOOTH DISORDER 159 0.0071
240 HYPERSENSITIVITY 1309 0.0070
241 THROAT TIGHTNESS 188 0.0069
242 ENERGY INCREASED 41 0.0069
243 ATELECTASIS 67 0.0069
244 OBSTRUCTIVE AIRWAYS DISORDER 77 0.0069
245 THROAT CANCER 29 0.0069
246 ERUCTATION 132 0.0068
247 PALPITATIONS 793 0.0068
248 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 477 0.0067
249 HYPOAESTHESIA ORAL 101 0.0067
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 113 0.0066
251 POTENTIATING DRUG INTERACTION 22 0.0065
252 DRUG USE DISORDER 55 0.0065
253 BRONCHIOLITIS 23 0.0065
254 MASTICATION DISORDER 20 0.0065
255 WITHDRAWAL SYNDROME 274 0.0065
256 COLITIS 247 0.0065
257 ALCOHOL USE 24 0.0065
258 UPPER-AIRWAY COUGH SYNDROME 53 0.0064
259 MAJOR DEPRESSION 47 0.0064
260 UNDERDOSE 468 0.0064
261 STOMATITIS 387 0.0064
262 PRIAPISM 22 0.0064
263 COLD SWEAT 112 0.0063
264 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 43 0.0063
265 PRODUCT PHYSICAL CONSISTENCY ISSUE 35 0.0063
266 RECTAL HAEMORRHAGE 269 0.0063
267 BIPOLAR DISORDER 68 0.0062
268 SUICIDAL BEHAVIOUR 26 0.0062
269 NEONATAL RESPIRATORY DISTRESS SYNDROME 22 0.0062
270 LOOSE TOOTH 20 0.0062
271 DRUG DEPENDENCE 988 0.0061
272 POST-TRAUMATIC STRESS DISORDER 41 0.0061
273 SNORING 23 0.0061
274 FORMICATION 42 0.0060
275 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
276 DRY THROAT 61 0.0060
277 POOR QUALITY SLEEP 129 0.0060
278 UMBILICAL HERNIA 28 0.0060
279 RESTLESSNESS 219 0.0060
280 RHINITIS 48 0.0059
281 ANGER 201 0.0059
282 NAUSEA 4699 0.0059
283 ARTERIOSCLEROSIS CORONARY ARTERY 39 0.0059
284 POOR QUALITY PRODUCT ADMINISTERED 62 0.0059
285 ANHEDONIA 154 0.0059
286 DRUG INEFFECTIVE 7659 0.0058
287 INITIAL INSOMNIA 58 0.0056
288 GINGIVAL BLEEDING 77 0.0056
289 SPUTUM DISCOLOURED 53 0.0056
290 PATENT DUCTUS ARTERIOSUS 22 0.0055
291 TOOTH LOSS 114 0.0055
292 MALAISE 2409 0.0055
293 END STAGE RENAL DISEASE 99 0.0054
294 DRUG ABUSE 445 0.0053
295 INCREASED APPETITE 102 0.0053
296 MATERNAL EXPOSURE DURING PREGNANCY 472 0.0053
297 DIZZINESS 2627 0.0053
298 CARDIAC FLUTTER 34 0.0053
299 INSOMNIA 1400 0.0053
300 SELF-INJURIOUS IDEATION 22 0.0052
301 INTENTIONAL UNDERDOSE 38 0.0052
302 MOUTH SWELLING 30 0.0052
303 ALCOHOLISM 22 0.0051
304 MUSCULOSKELETAL CHEST PAIN 79 0.0051
305 URINE ODOUR ABNORMAL 30 0.0051
306 FOETAL GROWTH RESTRICTION 31 0.0051
307 HEART RATE IRREGULAR 115 0.0051
308 NASAL POLYPS 25 0.0051
309 PRODUCT COLOUR ISSUE 26 0.0051
310 OROPHARYNGEAL PAIN 467 0.0050
311 COLITIS ULCERATIVE 223 0.0050
312 FEELING DRUNK 37 0.0050
313 SKIN IRRITATION 228 0.0050
314 PRODUCT SOLUBILITY ABNORMAL 25 0.0049
315 PRODUCT PACKAGING ISSUE 47 0.0049
316 POOR QUALITY DRUG ADMINISTERED 32 0.0049
317 THERAPEUTIC PRODUCT EFFECT VARIABLE 19 0.0049
318 TRANSFUSION 51 0.0049
319 FLATULENCE 276 0.0049
320 HYPERVENTILATION 28 0.0048
321 SINUS TACHYCARDIA 68 0.0048
322 PANIC ATTACK 174 0.0048
323 ANXIETY 1356 0.0048
324 HYPERPHAGIA 19 0.0048
325 SKIN REACTION 67 0.0048
326 OBSESSIVE-COMPULSIVE DISORDER 38 0.0047
327 VISUAL DISTURBANCE 27 0.0047
328 MATERNAL EXPOSURE DURING BREAST FEEDING 19 0.0047
329 HYPERHIDROSIS 603 0.0047
330 ANOREXIA 60 0.0047
331 SWOLLEN TONGUE 145 0.0046
332 SKIN WARM 27 0.0046
333 BURNING SENSATION 325 0.0046
334 CHEILITIS 25 0.0046
335 HALLUCINATION, AUDITORY 73 0.0046
336 ARTERIOSCLEROSIS 43 0.0046
337 SENSORY DISTURBANCE 73 0.0045
338 DRUG TOLERANCE 23 0.0045
339 HYPERLIPIDAEMIA 54 0.0045
340 RASH GENERALISED 117 0.0045
341 TOOTH ABSCESS 46 0.0045
342 CHRONIC KIDNEY DISEASE 343 0.0045
343 PULMONARY MASS 67 0.0045
344 HAEMATOCHEZIA 248 0.0045
345 MIOSIS 36 0.0045
346 PRE-EXISTING CONDITION IMPROVED 28 0.0045
347 TROPONIN INCREASED 34 0.0045
348 FEELING ABNORMAL 1070 0.0045
349 TREMOR 741 0.0045
350 SNEEZING 100 0.0045
351 PRODUCTIVE COUGH 212 0.0044
352 THERAPEUTIC RESPONSE UNEXPECTED 199 0.0044
353 WHEEZING 260 0.0044
354 ACCIDENTAL OVERDOSE 159 0.0043
355 SLEEP DISORDER 306 0.0043
356 WRONG TECHNIQUE IN DRUG USAGE PROCESS 157 0.0043
357 CHOKING 84 0.0043
358 MALNUTRITION 48 0.0043
359 PRODUCT DOSE OMISSION 279 0.0043
360 PAROSMIA 32 0.0042
361 DRUG WITHDRAWAL SYNDROME 369 0.0042
362 PRODUCT USE ISSUE 787 0.0042
363 DRY MOUTH 338 0.0042
364 ABDOMINAL DISCOMFORT 693 0.0041
365 MIDDLE INSOMNIA 77 0.0041
366 SCHIZOPHRENIA 50 0.0041
367 SPINAL OSTEOARTHRITIS 36 0.0041
368 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21 0.0041
369 INCREASED UPPER AIRWAY SECRETION 21 0.0041
370 EATING DISORDER 87 0.0041
371 OSTEOPENIA 62 0.0041
372 EOSINOPHIL COUNT INCREASED 34 0.0041
373 ELECTROCARDIOGRAM ABNORMAL 32 0.0041
374 HYPERCHLORHYDRIA 24 0.0041
375 SKIN LACERATION 44 0.0040
376 SKIN ABRASION 19 0.0040
377 JAW DISORDER 22 0.0040
378 AGITATION 295 0.0040
379 PARTIAL SEIZURES 21 0.0040
380 CHEST PAIN 742 0.0040
381 APHTHOUS ULCER 31 0.0040
382 PULMONARY CONGESTION 52 0.0039
383 AFFECTIVE DISORDER 31 0.0039
384 DYSLIPIDAEMIA 20 0.0039
385 INFUSION RELATED REACTION 261 0.0039
386 DROOLING 27 0.0039
387 CONCOMITANT DISEASE AGGRAVATED 24 0.0039
388 SCRATCH 41 0.0039
389 PARANOIA 67 0.0039
390 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
391 MOOD SWINGS 123 0.0039
392 SCAB 44 0.0039
393 INTENTIONAL PRODUCT MISUSE 336 0.0038
394 EXERCISE TOLERANCE DECREASED 22 0.0038
395 TOXICITY TO VARIOUS AGENTS 643 0.0038
396 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 271 0.0038
397 BRAIN OEDEMA 48 0.0038
398 CHEST DISCOMFORT 388 0.0038
399 VOMITING 1777 0.0038
400 CRYING 137 0.0038
401 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
402 MOOD ALTERED 102 0.0037
403 DRUG EXPOSURE DURING PREGNANCY 127 0.0037
404 NEUTROPHIL COUNT INCREASED 38 0.0037
405 PULMONARY OEDEMA 166 0.0037
406 DYSPNOEA EXERTIONAL 139 0.0037
407 MYOCLONUS 44 0.0037
408 ERYTHEMA 755 0.0037
409 CARDIOMEGALY 45 0.0037
410 UNRESPONSIVE TO STIMULI 94 0.0036
411 MENTAL STATUS CHANGES 101 0.0036
412 DISORIENTATION 144 0.0036
413 GASTROOESOPHAGEAL REFLUX DISEASE 290 0.0036
414 DISTURBANCE IN ATTENTION 194 0.0036
415 DEPRESSED MOOD 190 0.0036
416 HYPOVOLAEMIA 21 0.0036
417 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 22 0.0036
418 PSYCHOTIC DISORDER 105 0.0036
419 HYPOXIA 125 0.0035
420 THINKING ABNORMAL 66 0.0035
421 SUICIDAL IDEATION 324 0.0035
422 FEELING HOT 216 0.0035
423 SOMNAMBULISM 23 0.0035
424 HEADACHE 2194 0.0035
425 MULTIPLE INJURIES 22 0.0035
426 ANGINA PECTORIS 100 0.0035
427 MYOCARDITIS 40 0.0035
428 SOCIAL AVOIDANT BEHAVIOUR 20 0.0035
429 MITRAL VALVE INCOMPETENCE 39 0.0034
430 EXPOSURE DURING PREGNANCY 214 0.0034
431 FEELING OF BODY TEMPERATURE CHANGE 20 0.0034
432 SLEEP APNOEA SYNDROME 65 0.0034
433 RENAL CYST 27 0.0034
434 FEAR 91 0.0034
435 FACIAL PAIN 30 0.0034
436 LOSS OF CONSCIOUSNESS 429 0.0033
437 BLISTER 188 0.0033
438 AGEUSIA 83 0.0033
439 THIRST 59 0.0033
440 INTENTIONAL PRODUCT USE ISSUE 289 0.0033
441 HALLUCINATION 248 0.0033
442 TRICUSPID VALVE INCOMPETENCE 26 0.0033
443 PRODUCT PHYSICAL ISSUE 66 0.0033
444 POISONING 41 0.0033
445 RENAL TUBULAR NECROSIS 32 0.0033
446 MENTAL IMPAIRMENT 79 0.0033
447 PRODUCT LABEL ISSUE 22 0.0032
448 INTERVERTEBRAL DISC DEGENERATION 30 0.0032
449 URTICARIA 541 0.0032
450 ACUTE RESPIRATORY FAILURE 62 0.0032
451 LOCAL SWELLING 56 0.0032
452 GASTRIC DISORDER 110 0.0032
453 MEDICATION ERROR 178 0.0032
454 SKIN PLAQUE 27 0.0032
455 CONVULSION 183 0.0032
456 ABDOMINAL PAIN UPPER 654 0.0032
457 HUNGER 44 0.0032
458 DYSARTHRIA 117 0.0031
459 AGGRESSION 155 0.0031
460 DRUG INTERACTION 491 0.0031
461 BLOOD PRESSURE INCREASED 472 0.0031
462 PALLOR 84 0.0031
463 DEPRESSION 702 0.0031
464 DRUG DIVERSION 19 0.0031
465 OBESITY 49 0.0031
466 NERVE INJURY 34 0.0031
467 ARTERIAL OCCLUSIVE DISEASE 24 0.0031
468 ORTHOSTATIC HYPOTENSION 53 0.0030
469 LUNG NEOPLASM MALIGNANT 125 0.0030
470 SCAR 52 0.0030
471 MENTAL DISORDER 131 0.0030
472 HEPATIC STEATOSIS 56 0.0030
473 LOSS OF LIBIDO 27 0.0030
474 MOUTH HAEMORRHAGE 22 0.0030
475 DRUG DOSE OMISSION 493 0.0030
476 UPPER GASTROINTESTINAL HAEMORRHAGE 50 0.0030
477 DRUG LEVEL INCREASED 49 0.0030
478 RASH MACULAR 103 0.0029
479 ABNORMAL BEHAVIOUR 116 0.0029
480 MANIA 48 0.0029
481 ISCHAEMIC STROKE 52 0.0029
482 CONSTIPATION 634 0.0029
483 MUSCLE TIGHTNESS 47 0.0029
484 CARDIAC MURMUR 25 0.0029
485 LIP SWELLING 96 0.0029
486 DELIRIUM 100 0.0029
487 APATHY 42 0.0029
488 LACERATION 27 0.0029
489 RESPIRATORY DISTRESS 79 0.0029
490 RASH 1241 0.0028
491 COUGH 797 0.0028
492 HALLUCINATION, VISUAL 60 0.0028
493 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 83 0.0028
494 HEPATITIS C 34 0.0028
495 GRAND MAL CONVULSION 26 0.0028
496 DIVERTICULUM 20 0.0028
497 SINUS CONGESTION 38 0.0028
498 SEROTONIN SYNDROME 54 0.0028
499 PRURITUS 1079 0.0028
500 ABNORMAL FAECES 23 0.0028
501 PERSONALITY CHANGE 26 0.0028
502 DIZZINESS POSTURAL 27 0.0028
503 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 51 0.0028
504 PAIN IN EXTREMITY 817 0.0028
505 HAEMOPTYSIS 77 0.0028
506 INCORRECT DOSE ADMINISTERED 630 0.0028
507 SEDATION 72 0.0027
508 SWELLING FACE 179 0.0027
509 FEELING COLD 76 0.0027
510 PRODUCT USE COMPLAINT 43 0.0027
511 EAR DISCOMFORT 28 0.0027
512 EMOTIONAL DISORDER 84 0.0027
513 RIB FRACTURE 56 0.0027
514 ILL-DEFINED DISORDER 165 0.0027
515 SKIN DISORDER 90 0.0027
516 PARAESTHESIA 424 0.0027
517 TACHYCARDIA 239 0.0027
518 HYPERSOMNIA 77 0.0027
519 NECK PAIN 149 0.0027
520 BLOOD MAGNESIUM DECREASED 23 0.0027
521 PHARYNGEAL SWELLING 26 0.0027
522 ACUTE KIDNEY INJURY 404 0.0026
523 DYSPNOEA 1491 0.0026
524 ABDOMINAL DISTENSION 274 0.0026
525 RESPIRATORY ARREST 72 0.0026
526 FRUSTRATION TOLERANCE DECREASED 21 0.0026
527 DECUBITUS ULCER 21 0.0026
528 BLINDNESS TRANSIENT 19 0.0026
529 INCORRECT ROUTE OF DRUG ADMINISTRATION 92 0.0026
530 ASPIRATION 28 0.0026
531 HYPERAESTHESIA 21 0.0026
532 HIATUS HERNIA 33 0.0025
533 BLOOD TRIGLYCERIDES INCREASED 45 0.0025
534 DYSPHONIA 147 0.0025
535 RESPIRATORY FAILURE 182 0.0025
536 MYDRIASIS 32 0.0025
537 SENSORY LOSS 20 0.0025
538 CORONARY ARTERY OCCLUSION 34 0.0025
539 RASH PRURITIC 134 0.0025
540 BLOOD POTASSIUM INCREASED 40 0.0025
541 HAEMATEMESIS 62 0.0024
542 PNEUMONIA ASPIRATION 61 0.0024
543 HYPOAESTHESIA 365 0.0024
544 SKIN ULCER 63 0.0024
545 MUSCLE TWITCHING 56 0.0024
546 TOOTH INFECTION 32 0.0024
547 CYANOSIS 38 0.0024
548 WEIGHT INCREASED 540 0.0024
549 OSTEOPOROSIS 99 0.0024
550 TENDERNESS 25 0.0024
551 DISCOMFORT 146 0.0024
552 RENAL INJURY 71 0.0024
553 MIGRAINE 228 0.0024
554 BLOOD SODIUM DECREASED 45 0.0024
555 HYPERCHOLESTEROLAEMIA 23 0.0024
556 MUSCULOSKELETAL DISCOMFORT 41 0.0024
557 CONFUSIONAL STATE 384 0.0024
558 MYOCARDIAL ISCHAEMIA 27 0.0024
559 INCONTINENCE 25 0.0024
560 GASTROINTESTINAL PAIN 26 0.0024
561 LETHARGY 135 0.0023
562 CORONARY ARTERY DISEASE 71 0.0023
563 RASH ERYTHEMATOUS 112 0.0023
564 HYPOKALAEMIA 108 0.0023
565 ELECTROLYTE IMBALANCE 27 0.0023
566 LEUKOCYTOSIS 42 0.0023
567 EAR PAIN 45 0.0023
568 SKIN SWELLING 20 0.0023
569 PLATELET COUNT INCREASED 30 0.0023
570 SUPRAVENTRICULAR TACHYCARDIA 22 0.0023
571 SOMNOLENCE 462 0.0023
572 ACUTE CORONARY SYNDROME 19 0.0023
573 BRAIN INJURY 23 0.0023
574 ACCIDENTAL EXPOSURE TO PRODUCT 236 0.0023
575 BLOOD CALCIUM INCREASED 20 0.0023
576 ATAXIA 27 0.0023
577 ACUTE MYOCARDIAL INFARCTION 67 0.0023
578 BRONCHITIS 167 0.0023
579 ASTHMA 255 0.0023
580 RESTLESS LEGS SYNDROME 41 0.0023
581 HYPERTENSION 475 0.0022
582 FLANK PAIN 21 0.0022
583 ABDOMINAL PAIN 520 0.0022
584 SPEECH DISORDER 117 0.0022
585 CARDIOMYOPATHY 33 0.0022
586 VASCULITIS 26 0.0022
587 CIRCULATORY COLLAPSE 38 0.0022
588 RASH PAPULAR 50 0.0022
589 ANAL INCONTINENCE 20 0.0022
590 CONTRAINDICATED PRODUCT ADMINISTERED 67 0.0022
591 PNEUMOTHORAX 35 0.0022
592 RESPIRATORY DEPRESSION 27 0.0022
593 ADVERSE EVENT 203 0.0022
594 CELLULITIS 111 0.0022
595 MYOCARDIAL INFARCTION 384 0.0022
596 SKIN DISCOLOURATION 101 0.0022
597 MUSCLE STRAIN 19 0.0022
598 PRODUCT ODOUR ABNORMAL 23 0.0022
599 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
600 DRUG PRESCRIBING ERROR 42 0.0022
601 LACRIMATION INCREASED 66 0.0022
602 AFFECT LABILITY 21 0.0022
603 RENAL PAIN 23 0.0022
604 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
605 RENAL FAILURE 288 0.0022
606 HAEMATOCRIT DECREASED 43 0.0022
607 UROSEPSIS 20 0.0022
608 BLOOD CHOLESTEROL INCREASED 101 0.0022
609 OXYGEN SATURATION DECREASED 121 0.0022
610 INJURY 151 0.0021
611 ILLNESS 221 0.0021
612 ANKLE FRACTURE 33 0.0021
613 SYNCOPE 213 0.0021
614 SKIN LESION 58 0.0021
615 WEIGHT DECREASED 589 0.0021
616 BONE DENSITY DECREASED 66 0.0021
617 BACTERAEMIA 25 0.0021
618 RESPIRATORY DISORDER 63 0.0021
619 GASTRIC ULCER 40 0.0021
620 COMPLETED SUICIDE 175 0.0021
621 FAECES DISCOLOURED 45 0.0021
622 DIABETES MELLITUS 158 0.0021
623 ASTHENIA 779 0.0021
624 DERMATITIS ALLERGIC 26 0.0021
625 ERECTILE DYSFUNCTION 53 0.0021
626 BONE LOSS 31 0.0021
627 TACHYPNOEA 28 0.0021
628 INTERVERTEBRAL DISC PROTRUSION 45 0.0021
629 INTENTIONAL OVERDOSE 132 0.0021
630 ELECTROCARDIOGRAM QT PROLONGED 74 0.0021
631 EMOTIONAL DISTRESS 249 0.0021
632 ROAD TRAFFIC ACCIDENT 86 0.0021
633 HYPERKALAEMIA 72 0.0021
634 VITAMIN D DEFICIENCY 20 0.0020
635 SEXUAL DYSFUNCTION 24 0.0020
636 BLOOD GLUCOSE INCREASED 385 0.0020
637 COMA 97 0.0020
638 ADVERSE REACTION 27 0.0020
639 IMPAIRED DRIVING ABILITY 23 0.0020
640 DEPRESSED LEVEL OF CONSCIOUSNESS 80 0.0020
641 VENTRICULAR EXTRASYSTOLES 21 0.0020
642 BLOOD PRESSURE DECREASED 134 0.0020
643 FACE OEDEMA 34 0.0020
644 PRESCRIBED OVERDOSE 39 0.0020
645 APHONIA 28 0.0020
646 FOOT FRACTURE 38 0.0020
647 PANCREATITIS ACUTE 45 0.0020
648 BLOOD PRESSURE SYSTOLIC INCREASED 39 0.0020
649 VENTRICULAR TACHYCARDIA 33 0.0020
650 PHOTOSENSITIVITY REACTION 33 0.0020
651 ANAEMIA 381 0.0020
652 EYE SWELLING 74 0.0020
653 CARDIAC ARREST 164 0.0020
654 HYPOTHERMIA 20 0.0020
655 FIBROMYALGIA 48 0.0020
656 DYSSTASIA 57 0.0020
657 ULCER 31 0.0019
658 HYPERGLYCAEMIA 71 0.0019
659 ADVERSE DRUG REACTION 175 0.0019
660 HEMIPARESIS 33 0.0019
661 QUALITY OF LIFE DECREASED 26 0.0019
662 PHARYNGITIS 24 0.0019
663 HEPATOMEGALY 19 0.0019
664 C-REACTIVE PROTEIN INCREASED 70 0.0019
665 IMPAIRED WORK ABILITY 41 0.0019
666 OEDEMA PERIPHERAL 233 0.0019
667 HYPOTONIA 19 0.0019
668 HEAD INJURY 60 0.0019
669 BURSITIS 23 0.0019
670 NIGHT SWEATS 61 0.0019
671 NASAL CONGESTION 111 0.0019
672 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 339 0.0019
673 PRODUCT ADMINISTRATION ERROR 38 0.0019
674 OSTEOMYELITIS 34 0.0019
675 ENCEPHALOPATHY 46 0.0019
676 TYPE 2 DIABETES MELLITUS 63 0.0019
677 HOT FLUSH 141 0.0019
678 ROTATOR CUFF SYNDROME 24 0.0019
679 SMALL INTESTINAL OBSTRUCTION 23 0.0019
680 SINUS DISORDER 37 0.0019
681 CARDIO-RESPIRATORY ARREST 78 0.0019
682 ANOSMIA 27 0.0019
683 SEIZURE 215 0.0019
684 DECREASED ACTIVITY 20 0.0019
685 CARDIOVASCULAR DISORDER 47 0.0018
686 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19 0.0018
687 TOOTH EXTRACTION 23 0.0018
688 ABORTION SPONTANEOUS 74 0.0018
689 BLOOD COUNT ABNORMAL 28 0.0018
690 AMNESIA 120 0.0018
691 BLOOD CREATINE PHOSPHOKINASE INCREASED 53 0.0018
692 DEVICE FAILURE 28 0.0018
693 SWELLING 171 0.0018
694 WHITE BLOOD CELL COUNT INCREASED 70 0.0018
695 ADRENAL INSUFFICIENCY 22 0.0018
696 LYMPHOCYTE COUNT DECREASED 32 0.0018
697 MYALGIA 307 0.0018
698 EJECTION FRACTION DECREASED 28 0.0018
699 DRUG INTOLERANCE 174 0.0018
700 RASH MACULO-PAPULAR 40 0.0018
701 JOINT DISLOCATION 19 0.0018
702 LUNG DISORDER 88 0.0018
703 DRUG EFFECT INCOMPLETE 65 0.0018
704 SUICIDE ATTEMPT 108 0.0018
705 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
706 DYSPHAGIA 168 0.0018
707 AKATHISIA 24 0.0018
708 PRODUCT AVAILABILITY ISSUE 40 0.0018
709 MUSCULOSKELETAL PAIN 92 0.0018
710 PAIN 1074 0.0017
711 PERIPHERAL COLDNESS 24 0.0017
712 LIMB DISCOMFORT 54 0.0017
713 VERTIGO 106 0.0017
714 HEART RATE DECREASED 61 0.0017
715 NOCTURIA 21 0.0017
716 SEPTIC SHOCK 75 0.0017
717 MASS 24 0.0017
718 PULMONARY EMBOLISM 163 0.0017
719 CARPAL TUNNEL SYNDROME 24 0.0017
720 PLEURAL EFFUSION 104 0.0017
721 ANAPHYLACTIC REACTION 94 0.0017
722 PREGNANCY 34 0.0017
723 ACUTE RESPIRATORY DISTRESS SYNDROME 30 0.0017
724 SEASONAL ALLERGY 24 0.0017
725 HAEMORRHOIDS 33 0.0017
726 PERICARDIAL EFFUSION 39 0.0017
727 PRESYNCOPE 41 0.0017
728 DYSURIA 62 0.0017
729 INTENTIONAL SELF-INJURY 34 0.0017
730 BRONCHOSPASM 24 0.0017
731 CONDITION AGGRAVATED 511 0.0017
732 EXTRA DOSE ADMINISTERED 68 0.0017
733 ACCIDENT 20 0.0017
734 DELUSION 26 0.0017
735 RENAL FAILURE ACUTE 71 0.0017
736 TRANSIENT ISCHAEMIC ATTACK 56 0.0017
737 PYREXIA 574 0.0017
738 HYPOTENSION 330 0.0016
739 HEAD DISCOMFORT 29 0.0016
740 HYPONATRAEMIA 92 0.0016
741 BACK PAIN 377 0.0016
742 LYMPHADENOPATHY 57 0.0016
743 PARALYSIS 23 0.0016
744 DEHYDRATION 214 0.0016
745 BEDRIDDEN 21 0.0016
746 HYPOTHYROIDISM 51 0.0016
747 GASTRITIS 42 0.0016
748 CHROMATURIA 36 0.0016
749 JOINT INJURY 34 0.0016
750 MUSCLE RIGIDITY 19 0.0016
751 RHINORRHOEA 102 0.0016
752 VISION BLURRED 216 0.0016
753 DIARRHOEA 1013 0.0016
754 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 53 0.0016
755 BODY TEMPERATURE INCREASED 32 0.0016
756 DISABILITY 31 0.0016
757 EPISTAXIS 117 0.0016
758 BLOOD POTASSIUM DECREASED 47 0.0016
759 COAGULOPATHY 26 0.0016
760 SKIN BURNING SENSATION 111 0.0015
761 BLOOD CREATININE INCREASED 101 0.0015
762 LIMB INJURY 42 0.0015
763 TINNITUS 71 0.0015
764 BLOOD PRESSURE FLUCTUATION 37 0.0015
765 DECREASED APPETITE 358 0.0015
766 HYPERCALCAEMIA 19 0.0015
767 GENERALISED OEDEMA 19 0.0015
768 CEREBROVASCULAR ACCIDENT 257 0.0015
769 CEREBRAL INFARCTION 37 0.0015
770 SINUSITIS 155 0.0015
771 UPPER LIMB FRACTURE 30 0.0015
772 EPILEPSY 46 0.0015
773 MUSCLE ATROPHY 19 0.0015
774 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 72 0.0015
775 PNEUMONIA 485 0.0015
776 OSTEOARTHRITIS 63 0.0015
777 BONE DISORDER 27 0.0015
778 LIVER FUNCTION TEST ABNORMAL 43 0.0015
779 DEEP VEIN THROMBOSIS 96 0.0015
780 PRODUCT USE IN UNAPPROVED INDICATION 366 0.0015
781 BACK DISORDER 24 0.0015
782 GASTROINTESTINAL HAEMORRHAGE 123 0.0015
783 METABOLIC ACIDOSIS 47 0.0015
784 ACTIVITIES OF DAILY LIVING IMPAIRED 29 0.0015
785 MOVEMENT DISORDER 47 0.0015
786 CHOLELITHIASIS 48 0.0015
787 MULTIPLE FRACTURES 24 0.0015
788 PRODUCT PREPARATION ERROR 30 0.0015
789 LOWER LIMB FRACTURE 28 0.0015
790 RESPIRATORY TRACT CONGESTION 23 0.0014
791 ANGIOEDEMA 64 0.0014
792 HYPOKINESIA 21 0.0014
793 BALANCE DISORDER 125 0.0014
794 SHOCK 33 0.0014
795 PNEUMONITIS 39 0.0014
796 DERMATITIS 30 0.0014
797 DYSKINESIA 58 0.0014
798 FEBRILE NEUTROPENIA 94 0.0014
799 POLLAKIURIA 59 0.0014
800 HEPATOCELLULAR INJURY 20 0.0014
801 DIVERTICULITIS 39 0.0014
802 HYPOGLYCAEMIA 68 0.0014
803 SUBDURAL HAEMATOMA 20 0.0014
804 WOUND 39 0.0014
805 MUSCLE SPASMS 256 0.0014
806 CARDIOGENIC SHOCK 20 0.0014
807 IMPAIRED GASTRIC EMPTYING 19 0.0014
808 PULMONARY HYPERTENSION 29 0.0014
809 NEUTROPENIA 189 0.0014
810 SEPSIS 155 0.0014
811 DIPLOPIA 36 0.0014
812 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 76 0.0014
813 URINARY INCONTINENCE 41 0.0014
814 GASTROENTERITIS 20 0.0014
815 OEDEMA 74 0.0014
816 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
817 MUSCULAR WEAKNESS 153 0.0013
818 FATIGUE 1046 0.0013
819 RHABDOMYOLYSIS 56 0.0013
820 UPPER RESPIRATORY TRACT INFECTION 62 0.0013
821 FALL 446 0.0013
822 BRADYCARDIA 71 0.0013
823 DEAFNESS 35 0.0013
824 PERIPHERAL SWELLING 206 0.0013
825 STAPHYLOCOCCAL INFECTION 44 0.0013
826 GENERALISED TONIC-CLONIC SEIZURE 22 0.0013
827 INTESTINAL OBSTRUCTION 50 0.0013
828 ACUTE HEPATIC FAILURE 18 0.0013
829 IRRITABLE BOWEL SYNDROME 28 0.0013
830 THERAPY CESSATION 67 0.0013
831 JAUNDICE 35 0.0013
832 DRUG EFFECT DECREASED 70 0.0013
833 PANCREATITIS 68 0.0013
834 KIDNEY INFECTION 25 0.0013
835 CHILLS 149 0.0013
836 ARRHYTHMIA 60 0.0013
837 ABDOMINAL PAIN LOWER 32 0.0013
838 OCULAR HYPERAEMIA 60 0.0013
839 TRANSAMINASES INCREASED 28 0.0013
840 BLOOD UREA INCREASED 21 0.0013
841 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
842 CARDIAC DISORDER 116 0.0012
843 CONTUSION 119 0.0012
844 GAIT DISTURBANCE 236 0.0012
845 FEEDING DISORDER 25 0.0012
846 THYROID DISORDER 19 0.0012
847 TASTE DISORDER 25 0.0012
848 LOWER RESPIRATORY TRACT INFECTION 56 0.0012
849 URINARY RETENTION 41 0.0012
850 INFLUENZA 137 0.0012
851 INTERNATIONAL NORMALISED RATIO INCREASED 35 0.0012
852 VAGINAL HAEMORRHAGE 53 0.0012
853 HIP FRACTURE 39 0.0012
854 BLOOD URINE PRESENT 23 0.0012
855 MEMORY IMPAIRMENT 166 0.0012
856 DIABETIC KETOACIDOSIS 29 0.0012
857 EOSINOPHILIA 21 0.0012
858 BONE PAIN 70 0.0012
859 THROMBOSIS 96 0.0012
860 LIVER INJURY 29 0.0012
861 PHOTOPHOBIA 22 0.0012
862 PRODUCT SUBSTITUTION ISSUE 67 0.0012
863 FLUID RETENTION 59 0.0012
864 APHASIA 35 0.0012
865 CARDIAC FAILURE CONGESTIVE 93 0.0012
866 MULTI-ORGAN FAILURE 20 0.0012
867 BLOOD PRESSURE ABNORMAL 23 0.0012
868 RED BLOOD CELL COUNT DECREASED 33 0.0012
869 INFLUENZA LIKE ILLNESS 95 0.0012
870 CHOLESTASIS 22 0.0011
871 CEREBRAL HAEMORRHAGE 41 0.0011
872 HAEMOGLOBIN DECREASED 117 0.0011
873 THERAPEUTIC PRODUCT EFFECT DECREASED 50 0.0011
874 HAEMATURIA 38 0.0011
875 ATRIAL FIBRILLATION 108 0.0011
876 GASTROENTERITIS VIRAL 20 0.0011
877 MUCOSAL INFLAMMATION 29 0.0011
878 HOSPITALISATION 169 0.0011
879 CYTOKINE RELEASE SYNDROME 22 0.0011
880 PULMONARY FIBROSIS 21 0.0011
881 POST PROCEDURAL COMPLICATION 21 0.0011
882 EAR INFECTION 29 0.0011
883 NERVOUS SYSTEM DISORDER 34 0.0011
884 HERNIA 21 0.0011
885 CARDIAC FAILURE 87 0.0011
886 DYSTONIA 21 0.0011
887 RESPIRATORY TRACT INFECTION 28 0.0011
888 BLOOD BILIRUBIN INCREASED 29 0.0011
889 GLYCOSYLATED HAEMOGLOBIN INCREASED 27 0.0011
890 CYSTITIS 34 0.0011
891 ABASIA 26 0.0011
892 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0010
893 SPINAL FRACTURE 21 0.0010
894 PELVIC PAIN 19 0.0010
895 HYPOACUSIS 45 0.0010
896 MUSCULOSKELETAL STIFFNESS 91 0.0010
897 URINARY TRACT INFECTION 177 0.0010
898 THROMBOCYTOPENIA 116 0.0010
899 NEOPLASM MALIGNANT 69 0.0010
900 JOINT STIFFNESS 27 0.0010
901 HEPATIC FAILURE 31 0.0010
902 COGNITIVE DISORDER 48 0.0010
903 NEPHROLITHIASIS 47 0.0010
904 SURGERY 60 0.0010
905 OFF LABEL USE 891 0.0010
906 GENERAL PHYSICAL HEALTH DETERIORATION 117 0.0010
907 EYE DISORDER 33 0.0010
908 VIRAL INFECTION 33 0.0010
909 GLAUCOMA 19 0.0010
910 ARTHRALGIA 410 0.0010
911 GASTROINTESTINAL DISORDER 88 0.0010
912 IMPAIRED HEALING 32 0.0010
913 PRODUCT DISPENSING ERROR 21 0.0010
914 LACTIC ACIDOSIS 31 0.0010
915 NEUROPATHY PERIPHERAL 91 0.0010
916 LEUKOPENIA 47 0.0009
917 FUNGAL INFECTION 31 0.0009
918 OSTEONECROSIS OF JAW 23 0.0009
919 UNEVALUABLE EVENT 70 0.0009
920 JOINT SWELLING 111 0.0009
921 LABORATORY TEST ABNORMAL 27 0.0009
922 VISUAL IMPAIRMENT 112 0.0009
923 HYPOPHAGIA 23 0.0009
924 EYE PRURITUS 30 0.0009
925 INFLAMMATION 46 0.0009
926 NASOPHARYNGITIS 164 0.0009
927 HAEMATOMA 23 0.0009
928 EXTRAPYRAMIDAL DISORDER 22 0.0009
929 RENAL DISORDER 41 0.0009
930 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
931 ARTHRITIS 68 0.0009
932 RENAL IMPAIRMENT 72 0.0009
933 BLOOD GLUCOSE DECREASED 41 0.0009
934 NO ADVERSE EVENT 154 0.0008
935 PRODUCT DOSE OMISSION ISSUE 249 0.0008
936 HAEMORRHAGE 87 0.0008
937 SKIN EXFOLIATION 70 0.0008
938 DRY EYE 41 0.0008
939 ALOPECIA 161 0.0008
940 THERAPEUTIC RESPONSE DECREASED 49 0.0008
941 MOBILITY DECREASED 58 0.0008
942 HEPATIC ENZYME INCREASED 55 0.0008
943 INTENTIONAL DOSE OMISSION 23 0.0008
944 FLUSHING 82 0.0008
945 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
946 DEMENTIA 22 0.0008
947 OSTEONECROSIS 25 0.0008
948 BLINDNESS 31 0.0008
949 INFECTION 109 0.0008
950 VISUAL ACUITY REDUCED 25 0.0008
951 TARDIVE DYSKINESIA 21 0.0007
952 ANAPHYLACTIC SHOCK 19 0.0007
953 MULTIPLE SCLEROSIS 35 0.0007
954 EYE PAIN 40 0.0007
955 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
956 DRY SKIN 93 0.0007
957 ECZEMA 36 0.0007
958 NEUTROPHIL COUNT DECREASED 28 0.0007
959 MULTIPLE SCLEROSIS RELAPSE 47 0.0007
960 ASCITES 20 0.0007
961 PANCYTOPENIA 38 0.0007
962 ASPARTATE AMINOTRANSFERASE INCREASED 35 0.0007
963 FEMUR FRACTURE 20 0.0006
964 THERAPY NON-RESPONDER 29 0.0006
965 ARTHROPATHY 35 0.0006
966 THERAPY INTERRUPTED 45 0.0006
967 HERPES ZOSTER 36 0.0006
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29 0.0006
969 ACNE 46 0.0006
970 PLATELET COUNT DECREASED 62 0.0006
971 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
972 PRODUCT STORAGE ERROR 50 0.0006
973 CATARACT 34 0.0006
974 GAIT INABILITY 19 0.0006
975 DISEASE PROGRESSION 62 0.0005
976 EYE IRRITATION 30 0.0005
977 LIVER DISORDER 23 0.0005
978 DEATH 428 0.0005
979 MALIGNANT NEOPLASM PROGRESSION 50 0.0005
980 DISEASE RECURRENCE 22 0.0005
981 PSORIASIS 60 0.0005
982 COVID-19 69 0.0004
983 DEVICE ISSUE 30 0.0003
984 RHEUMATOID ARTHRITIS 37 0.0003
985 INJECTION SITE REACTION 22 0.0003
986 TREATMENT FAILURE 25 0.0003
987 INJECTION SITE PRURITUS 19 0.0003
988 BREAST CANCER 25 0.0003
989 INJECTION SITE PAIN 81 0.0003
990 INJECTION SITE SWELLING 19 0.0002
991 INJECTION SITE ERYTHEMA 20 0.0002